SGO on the GO

Hormone replacement in patients with gynecological cancer has always been a controversial topic. The guests on this episode help to debunk the myths and give guidance on how to have these important conversations and when to offer HRT to our patients.Hosts: Nicole Dreibelbis, CRNP, WHNP-BC, Sarah Irish, DNP, APRN, FNP-BCGuests: Jessie Dorne, PA, Rachel Frankenthal, PA-C, MPH, MSCPAdditional Resources:https://heatherhirschacademy.com/course/managing-hormone-therapy-for-gynecologic-cancer-survivors/

This episode features recent updates presented at the 2025 European Society for Medical Oncology (ESMO) Congress in Berlin, Germany. Lisa Rauh-Benoit, MD, MPH, and Michelle Boisen, MD discuss data presented for trials including DUO-O, Rina-S/RAINFOL-1 , TV 205 and more, highlighting the key takeaways and implications for practice. View the accompanying PDF resource developed by the SGO Education Committee here (https://connected.sgo.org/content/highlights-esmo-2025). 

Stephen Bush, MD, Vice Chair of the SGO Coding and Reimbursement Committee and Kay Moyer, Director of Regulatory Affairs, CRD Associates, discuss changes in Medicare Part B policies and payments and how those impact gynecologic oncologists in 2026. Resources:SGO Comments to the Medicare Physician Fee Schedule: SGO-MPFS-PR-2026-_-FINAL.pdfAn Update on the CY2026 Medicare Physician Fee Schedule Final Rule | Society of Gynecologic Oncology

Listen to part 3 of the three-part series "Keeping up with the Chemos" focusing on the treatment of Interstitial Lung Disease (ILD). Moderator:Jennifer MacDonald, PharmD, BCOP Speakers: Charles Powell, MD, MBAPaolo Tarantino, MD, PhDIra Winer MD, PhD, FACOGFind the associated clinical practice statement published online in Gynecologic Oncology here (https://www.gynecologiconcology-online.net/article/S0090-8258(25)01007-8/abstract). 

Listen to part 2 of the three-part series "Keeping up with the Chemos" focusing on prevention and monitoring of Interstitial Lung Disease (ILD). Moderator:Jennifer MacDonald, PharmD, BCOP Speakers: Charles Powell, MD, MBAPaolo Tarantino, MD, PhDIra Winer MD, PhD, FACOGFind the associated clinical practice statement published online in Gynecologic Oncology here (https://www.gynecologiconcology-online.net/article/S0090-8258(25)01007-8/abstract). 

Listen to part 1 of the three-part series "Keeping up with the Chemos" on the therapies associated with Interstitial Lung Disease (ILD). Moderator:Jennifer MacDonald, PharmD, BCOP Speakers: Charles Powell, MD, MBAPaolo Tarantino, MD, PhDIra Winer MD, PhD, FACOGFind the associated clinical practice statement published online in Gynecologic Oncology here (https://www.gynecologiconcology-online.net/article/S0090-8258(25)01007-8/abstract). 

Kaitlin Nicholson, MD and Katherine Tucker, MD, from the SGO Coding and Reimbursement Committee share their expertise in time-based coding to support your billing of inpatient and outpatient visits.  One episode in a continuing series of podcasts on the basics of CPT coding from the SGO. Moderated by David Holtz, MD, Past Chair of the SGO Coding and Reimbursement Committee.

Carolyn Haunschild , MD and Sameer Sharma, MD, from the SGO Coding and Reimbursement Subcommittee share their expertise in E/M coding and discuss how risk of complications, morbidity and mortality of patient management factor into billing of inpatient and outpatient visits.  One episode in a continuing series of podcasts on the basics of CPT coding from the SGO. Moderated by David Holtz, MD, Past Chair of the SGO Coding and Reimbursement Subcommittee.

Kimberly Levinson, MD, MPH, and Kaitlin Nicholson, MD, from the SGO Coding and Reimbursement Committee share their expertise in E/M coding to demystify the use of medical complexity data to support your billing of inpatient and outpatient visits.  One episode in a continuing series of podcasts on the basics of CPT coding from the SGO. Moderated by David Holtz, MD, Past Chair of the SGO Coding and Reimbursement Committee. 

As we all know, cancer care can feel incredibly complicated and overwhelming to patients – many of whom may face logistical, financial, and social barriers. Tune in to part two, as the discussion continues between Dr. Emily Wu and the panel of nurse navigators on the multi-faceted function of navigators and how to incorporate nurse navigation into a clinical practice. Moderator:Emily Wu, MDOverlake Medical Center Speakers:Julie Rodriguez, BSN, RN, OCN University of New Mexico Jordan Henderson, BSN, RN, OCN, ONN-CG Director of Program Development, AONN+Sally (Cannon) Tormey, RN, BSEd, OCN HCA TriStar

As we all know, cancer care can feel incredibly complicated and overwhelming to patients – many of whom may face logistical, financial, and social barriers. Given the complexities of our healthcare systems, this episode provides insight on ways a clinical practice can better support their patients.Tune in to this two-part episode as the Dr. Emily Wu interviews a panel of nurse navigators on their unique experiences within the role, the multi-faceted function of navigators, and how to incorporate nurse navigation into a clinical practice. Moderator:Emily Wu, MDOverlake Medical Center Speakers:Julie Rodriguez, BSN, RN, OCN University of New Mexico Jordan Henderson, BSN, RN, OCN, ONN-CG Director of Program Development, AONN+Sally (Cannon) Tormey, RN, BSEd, OCN HCA TriStar

Allison Barrie, MD, and Stephen Bush, MD, from the SGO Coding and Reimbursement Subcommittee share their expertise in E/M coding to unlock the secrets of using the number and complexity of diagnoses to support your billing of inpatient and outpatient visits.  One episode in a continuing series of podcasts on the basics of CPT coding from the SGO. Moderated by David Holtz, MD, Chair of the SGO Coding and Reimbursement Subcommittee. 

During the SGO 2024 Winter Meeting, Wellness Committee volunteers asked SGO members what advice they would give to their younger selves. Members at various stages of their medical career offered words of wisdom for trainees and new attendings in gynecologic oncology. Tune in to hear about challenges that members experienced, their journey to growth and self-care, and how they learned to find support through community and mentorship. Moderator: Hui (Amy) Chen, MDSpeakers: Katherine Fuh, MD, PhD; Jessica Gillen, MD; Allison Puechl, MD; Jeb Brown, MD; Katie Essel, MD; Katya Papatla, MD; Lisa Landrum, MD, PhD; Ramez Eskander, MD; Ritu Salani, MD, MBA; Wendel Naumann, MD; Sarah Johnson, PharmD; Sarah Ackroyd, MD, MPH; Kathryn McGonigle, MD 

Maximizing reproductive fertility options is just as important as beating cancer, primarily bridging the gap for patient education and fertility resources. Join Dr. Jennifer MacDonald as she interviews Drs. Scott Richard and Rachel Danis, addressing premature ovarian failure, ovarian preservation, and how chemo agents, radiation, and surgery can affect the patient’s natural fertility options. 2024-2025 SGO Chemotherapy and Immunotherapy Subcommittee Lead and Moderator:Jennifer MacDonald, PharmD, BCOP  Speakers:  Scott Richard, MD  Rachel Blair Danis, MD, MS  

Listen to Dr. Jennifer MacDonald interview Drs. Scott Richard and Rachel Danis, discussing the importance of fertility preservation for cancer patients, partnering with a reproductive endocrinology and infertility clinic (REI) to expand fertility options for future family building, and patients utilizing grant/nonprofit funding resources to financially assist with fertility treatment options.2024-2025 SGO Chemotherapy Immunotherapy Subcommittee Lead and Moderator:Jennifer MacDonald, PharmD, BCOP  Speakers:  Scott Richard, MD  Rachel Blair Danis, MD, MS Potential Funding Resources: Livestrong is a nonprofit organization that helps people affected by cancer with resources, programs, and advocacy.The Chick Mission idea "hatched" when Amanda's fertility preservation coverage was denied by her insurance company. Staring down a long road of chemo, radiation and long-term drug therapy, Amanda understood the high likelihood of infertility after her treatment and decided to move forward covering the costs on her own. The idea of other patients choosing not to pursue preservation simply because of the cost barrier did not sit well - socioeconomic standing should not dictate whether anyone has an opportunity to have biological children after they battle and beat cancer.

This is the last of the three-part podcast series, Keeping up with the Chemos on CDK 4/6 inhibitors. Our multidisciplinary panel will discuss the challenges with patient monitoring while on CDK 4/6 inhibitors. When to dose adjust and hold or even discontinue CDK 4/6 inhibitors. Once again, the podcast ends with take home points for patient monitoring, medication management, and side effects while on CDK 4/6 inhibitors.  2024-2025 SGO Chemotherapy and Immunology Subcommittee Lead and Moderator:Jennifer MacDonald, PharmD, BCOP Speakers:  Julia Fehniger, MD Jodi L. Taraba, PharmD, MS, RPh, BCOP Siddhartha Yadav, M.B.B.S, MD

This is the second of the three-part podcast series, Keeping up with the Chemos on CDK 4/6 inhibitors. Our multidisciplinary panel will discuss the important information about the drug preparation and administration of CDK 4/6 inhibitors.  Focusing on dosing, supportive care, and patient education. The session ends with general take home points on administration and toxicity prevention interventions.2024-2025 SGO Chemotherapy and Immunology Subcommittee Lead and Moderator:Jennifer MacDonald, PharmD, BCOP Speakers: Julia Fehniger, MDJodi L. Taraba, PharmD, MS, RPh, BCOPSiddhartha Yadav, M.B.B.S, MD

This is the first of the three-part podcast series, Keeping up with the Chemos on CDK 4/6 inhibitors. After going over some general information on CDK 4/6 inhibitors including when to use the drug, toxicity, response rates, repeat biopsy, and line of therapy and treatment option. The multidisciplinary panel will discuss dosing and drug preparation for giving CDK 4/6 inhibitors. The session wraps up with some key take home points on CDK 4/6 inhibitors. 2024-2025 SGO Chemotherapy and Immunology Subcommittee Lead and Moderator:Jennifer MacDonald, PharmD, BCOP Speakers: Julia Fehniger, MDJodi L. Taraba, PharmD, MS, RPh, BCOPSiddhartha Yadav, M.B.B.S, MD

Let’s do this -- This podcast features patient advocates who share their experiences and offer valuable insights from their journeys as cervical cancer patients and survivors. It is hosted by the Health Equity Subcommittee, a division of the SGO Diversity, Inclusion, and Health Equity (DIHE) Committee.Moderators:Lindsay Kuroki, MD, MSCI, Washington University Physicians, DIHE Health Equity subcommittee ChairNancy Zhou, MD, Rutgers Health - NJMS, DIHE Health Equity subcommittee Member Speakers:Mindy Dunn, Cancer SurvivorLinda Ryan, Cancer Survivor and Patient Advocate Resource Links:Foundation for Women's Cancer (FWC) Cervical Cancer: Your Guide 

This is the last of the three-part podcast series, Keeping up with the Chemos on Trastuzumab Deruxtecan ENHERTU®. Our multidisciplinary panel will discuss the challenges with patient monitoring while on Trastuzumab Deruxtecan ENHERTU®. When to dose adjust and hold or even discontinue Trastuzumab Deruxtecan ENHERTU®. Once again, the podcast ends with take home points for patient monitoring and side effects while on Trastuzumab Deruxtecan ENHERTU®.  2023-2024 SGO Chemotherapy and Targeted Therapies Subcommittee Member and Moderator:Tracilyn Hall, MDSpeakers:Jennifer MacDonald, PharmD, BCOPKathleen Moore, MDBernard Tawfik, MD In honor of Endometrial Cancer Awareness Month, we encourage you to read the latest HER2 Molecular Card and Trastuzumab Deruxtecan ENHERTU® Chemotherapy Card available now on SGO ConnectEd.HER2 Molecular Card: https://connected.sgo.org/content/molecular-target-human-epidermal-growth-factor-receptor-2-her2Trastuzumab Deruxtecan ENHERTU® Chemotherapy Card: https://connected.sgo.org/content/chemotherapy-targeted-therapies-flash-cards

This is the second of the three-part podcast series, Keeping up with the Chemos on Trastuzumab Deruxtecan ENHERTU®.  Our multidisciplinary panel will discuss the important information about the drug preparation and administration of Trastuzumab Deruxtecan ENHERTU®.  Focusing on dosing, breast scoring, HER2, infusion reactions, lab examinations, and patient education. The session ends with general take home points on administration and toxicity prevention interventions.2023-2024 SGO Chemotherapy and Targeted Therapies Subcommittee Member and Moderator:Tracilyn Hall, MDSpeakers:Jennifer MacDonald, PharmD, BCOPKathleen Moore, MDBernard Tawfik, MD In honor of Endometrial Cancer Awareness Month, we encourage you to read the latest HER2 Molecular Card and Trastuzumab Deruxtecan ENHERTU® Chemotherapy Card available now on SGO ConnectEd.HER2 Molecular Card: https://connected.sgo.org/content/molecular-target-human-epidermal-growth-factor-receptor-2-her2Trastuzumab Deruxtecan ENHERTU® Chemotherapy Card: https://connected.sgo.org/content/chemotherapy-targeted-therapies-flash-cards

This is the first of the three-part podcast series, Keeping up with the Chemos on Trastuzumab Deruxtecan ENHERTU®. After going over some general information on Trastuzumab Deruxtecan ENHERTU® including when to use the drug, checking patient performance status, toxicity, response rates in breast, and line of therapy and treatment option. The multidisciplinary panel will discuss dosing and drug preparation for giving Trastuzumab Deruxtecan ENHERTU®. The session wraps up with some key take home points on Trastuzumab Deruxtecan ENHERTU®.  2023-2024 SGO Chemotherapy and Targeted Therapies Subcommittee Member and Moderator:Tracilyn Hall, MDSpeakers:Jennifer MacDonald, PharmD, BCOPKathleen Moore, MDBernard Tawfik, MD In honor of Endometrial Cancer Awareness Month, we encourage you to read the latest HER2 Molecular Card and Trastuzumab Deruxtecan ENHERTU® Chemotherapy Card available now on SGO ConnectEd.HER2 Molecular Card: https://connected.sgo.org/content/molecular-target-human-epidermal-growth-factor-receptor-2-her2Trastuzumab Deruxtecan ENHERTU® Chemotherapy Card: https://connected.sgo.org/content/chemotherapy-targeted-therapies-flash-cards

In this podcast, we will focus on same day discharge as part of Enhanced Recovery after Surgery (ERAS).Over the past two decades, and especially after the publication of the GOG LAP2 trial, minimally invasive surgery has been widely adopted in gynecologic oncology, as it is associated with lower rates of complications, and improved postoperative recovery and return to normal activity. Postoperative hospitalization is typically shorter after minimally invasive (MIS) hysterectomy, and many patients may even be candidates for discharge on the day of surgery, so-called same-day discharge (SDD).2023-2024 SGO ERAS Subcommittee Members and Speakers:Lee-may Chen, MD; Subcommittee Lead and ModeratorNawar Latif, MD, MPH, MSCEClarissa Polen-De, MDMichael Shu, MDCollin Sitler, DOBrenna Swift, MD, MASc, MSc, FRCSCDiogo Torres, MD

This episode is part 3 of the Immunotherapy podcast series, which continues discussion of common controversies affecting the use of immune checkpoint inhibitors (ICIs) in the clinic, such as optimal dosing strategies, influence of toxicity on response and survival, and sequencing. Moderator:Karin K. Shih, MDGynecologic Oncologist & Assistant Professor - Zucker School of Medicine at Hofstra/NorthwellSpeakers:Erin Zacholski, PharmD, BCOPAssistant Professor - VCU School of PharmacyClinical Pharmacy Specialist, Gynecologic Oncology -  VCU Health Massey Cancer CenterSarah Hayward, PharmD, BCOPClinical Pharmacy Specialist, Gynecologic Oncology - OU Health Stephenson Cancer Center

This episode is part 2 of the Immunotherapy Series, which reviews common controversies affecting daily use of immune checkpoint inhibitors (ICIs) in the clinic, such as treatment options for immune related adverse effects beyond corticosteroids, re-challenging after toxicity, use of ICIs in patients with auto-immune conditions, and drug interactions. Moderator:Karin K. Shih, MDGynecologic Oncologist & Assistant Professor - Zucker School of Medicine at Hofstra/NorthwellSpeakers:Erin Zacholski, PharmD, BCOPAssistant Professor - VCU School of PharmacyClinical Pharmacy Specialist, Gynecologic Oncology -  VCU Health Massey Cancer CenterSarah Hayward, PharmD, BCOPClinical Pharmacy Specialist, Gynecologic Oncology - OU Health Stephenson Cancer Center

Join Dr. Robert Neff as he interviews Drs. Kathleen Moore and Charles Leath, III to discuss the latest NRG Oncology updates on upcoming studies, research, and trials. The focus for the podcast is to bridge the gaps between SGO members and NRG Oncology.   Some questions covered during the interview: Since NRG just celebrated its 10-year anniversary during the Summer Meeting, what is the vision for NRG in the next 10 years?What are some of the successes within the past year for the Ovary Subcommittee?What were the most important highlights from the Cervix and Vulvar Subcommittee?Are there opportunities for new members to be involved? This episode was created by Dr. Robert Neff, 2023-2024 member of the SGO Education Committee's Clinical Trials Management/Concepts Subcommittee. Thanks to Drs. Moore and Leath, III for your contribution to this episode.Moderator:Robert Neff, MDSpeakers:Kathleen Moore, MDCharles Leath, III, MD 

Episode three of the Radiation Therapy podcast series discusses radiation techniques and management with regard to locally advanced cervical cancer.  Host/Moderator: Leigh A. Cantrell, MD, MSPHProfessor, Department of Obstetrics and Gynecology, Division of Gynecologic Oncology - University of VirginiaGuest Speaker:Kara Romano, M.D.Assistant Professor, Department of Radiation Oncology - University of Virginia

Join Dr. Janelle Darby, member of the SGO Clinical Trials Management/Concepts Subcommittee, as she interviews Drs. Evan Graboyes, Jeffrey Hines, and Bhavana Pothuri, addressing continued efforts to improve inclusion of racially and ethnically diverse patients in clinical trials.   Some topics covered during the interview:Barriers to clinical trial enrollment and retention among racially and ethnically diverse patient populations.Role of cooperative research groups in improving access to clinical trials for racially and ethnically diverse patient populations. Discussion of resources and strategies to improve recruitment and retention of racially and ethnically diverse patient populations in clinical trials.2023-2024 SGO  Clinical Trials Management/Concepts Subcommittee Member and Moderator:Janelle Pakish Darby, MDSpeakers:Evan Graboyes, MD, MPH, FACSJeffrey Hines, MDBhavana Pothuri, MD, MS

This podcast focuses on the surgical site infection reduction bundle as part of the ERAS guidelines that was first published in 2016 and updated in 2019, and the 2020 vulvar and vaginal surgeries ERAS guidelines.Before we dive into the SSI reduction bundle, we want to highlight the importance of patient education and participation in any ERAS protocol. Pre-operative education and psychological preparation is critical. Written information was determined to be superior to verbal in a randomized clinical trial in gynecologic oncology surgery.2023-2024 SGO ERAS Subcommittee Members and Speakers:Lee-may Chen, MD; Subcommittee Lead and ModeratorNawar Latif, MD, MPH, MSCECollin Sitler, DOBrenna Swift, MD, MASc, MSc, FRCSC

This is the last of the three-part podcast series, Keeping up with the Chemos on Trabectedin and Doxorubicin. Our multidisciplinary panel will discuss the challenges with patient monitoring while on Trabectedin and Doxorubicin. When to dose adjust and hold or even discontinue Trabectedin and Doxorubicin. Once again, the podcast ends with take home points for patient monitoring and side effects while on Trabectedin and Doxorubicin.  2023-2024 SGO Chemotherapy and Targeted Therapies Subcommittee Members and Moderators:Tracilyn Hall, MDJennifer MacDonald, PharmD, BCOPSpeakers:Sminu Bose, MDJoshua Cohen, MD Claire Marie Mach, PharmD, BCOP    

This is the second of the three-part podcast series, Keeping up with the Chemos on Trabectedin and Doxorubicin. Our multidisciplinary panel will discuss the important information about the drug preparation and administration of Trabectedin and Doxorubicin. Focusing on oral dosing, infusion pump setup, lab examinations, and patient education. The session ends with general take home points on administration and toxicity prevention interventions.2023-2024 SGO Chemotherapy and Targeted Therapies Subcommittee Members and Moderators:Tracilyn Hall, MD Jennifer MacDonald, PharmD, BCOPSpeakers:Sminu Bose, MDJoshua Cohen, MD Claire Marie Mach, PharmD, BCOP    

This is the first of the three-part podcast series, Keeping up with the Chemos on Trabectedin and Doxorubicin. After going over some general information on Trabectedin and Doxorubicin including when to use the drug, checking patient performance status, toxicity, and line of therapy and treatment option for recurring metastasis disease. The multidisciplinary panel will discuss dosing and drug preparation for giving Trabectedin and Doxorubicin. The session wraps up with some key take home points on Trabectedin and Doxorubicin.  2023-2024 SGO Chemotherapy and Targeted Therapies Subcommittee Members and Moderators:Tracilyn Hall, MDJennifer MacDonald, PharmD, BCOPSpeakers:Sminu Bose, MDJoshua Cohen, MD Claire Marie Mach, PharmD, BCOP    

Episode two of the Radiation Therapy podcast series discusses treatment of Oligometastatic disease, re-irradiation and role of palliative radiation, utilization of SBRT, introduction to proton therapy and mitigation of radiation-associated toxicities. Host: Mian M. Shahzad, MD, PhD Gynecologic Oncologist, H. Lee Moffitt Cancer CenterGuest Speaker: Michael Montejo, MDRadiation oncologist, H. Lee Moffitt Cancer Center 

This episode is part 1 of the Immunotherapy podcast series, which reviews immune-checkpoint inhibitors encountered in the gynecologic oncology setting, common immunotherapy toxicities and patient counseling on them, as well as the basic treatment course for patients with high-grade toxicities.Moderator: Karin K. Shih, MDGynecologic Oncologist & Assistant Professor - Zucker School of Medicine at Hofstra/Northwell Speakers: Erin Zacholski, PharmD, BCOP Assistant Professor - VCU School of PharmacyClinical Pharmacy Specialist, Gynecologic Oncology -  VCU Health Massey Cancer Center Sarah Hayward, PharmD, BCOPClinical Pharmacy Specialist, Gynecologic Oncology - OU Health Stephenson Cancer Center

This episode is part 1 of the Radiation Therapy podcast series, which looks to review and address the basic fundamentals of radiation therapy in the gynecologic oncology setting. Host: Mian M. Shahzad, MD PhD (Gynecologic Oncologist; H. Lee Moffitt Cancer Center)Guest Speaker: Michael Montejo, MD (Radiation oncologist; H. Lee Moffitt Cancer Center) 

This is the last of the three-part podcast series, Keeping up with the Chemos on Trametinib. Our multidisciplinary panel will discuss the challenges with patient monitoring while on Trametinib. When to dose adjust and hold or even discontinue Trametinib. Once again, the podcast ends with take home points for patient monitoring and side effects while on Trametinib.  2023-2024 SGO Chemotherapy and Targeted Therapies Subcommittee Members and Moderators:Tracilyn Hall, MDJennifer MacDonald, PharmD, BCOPSpeakers:Christina M. Davis, PharmD, BCOPDavid M. Gershenson, MD Rebecca L. Porter, MD, PhD 

This is the second of the three-part podcast series, Keeping up with the Chemos on Trametinib. Our multidisciplinary panel will discuss the important information about the drug preparation and administration of Trametinib. Focusing on oral dosing, lab examinations, prophylactic management of skincare reactions, and patient education. The session ends with general take home points on administration and toxicity prevention interventions.2023-2024 SGO Chemotherapy and Targeted Therapies Subcommittee Members and Moderators:Tracilyn Hall, MDJennifer MacDonald, PharmD, BCOPSpeakers:Christina M. Davis, PharmD, BCOPDavid M. Gershenson, MD Rebecca L. Porter, MD, PhD 

This is the first of the three-part podcast series, Keeping up with the Chemos on Trametinib. After going over some general information on Trametinib including mutation status considerations, baseline lab testing, ocular toxicity, and line of therapy. The multidisciplinary panel will discuss dosing and drug preparation for giving Trametinib. The session wraps up with some key take home points on Trametinib. 2023-2024 SGO Chemotherapy and Targeted Therapies Subcommittee Members and Moderators:Tracilyn Hall, MDJennifer MacDonald, PharmD, BCOP Speakers:Christina M. Davis, PharmD, BCOPDavid M. Gershenson, MD Rebecca L. Porter, MD, PhD 

The goal of this podcast is to continue our series on key concepts of enhanced recovery after surgery (ERAS). In September 2022, the SGO Education Committee's ERAS Subcommittee discussed why we do it, and in February 2023, we talked about how we do it. This podcast will complete our trilogy and discuss implementation or looking at how well we do it.Listen to Gregg Nelson, MD, PhD from the University of Calgary discuss ERAS implementation including some of the starting points, his experience in his own institution, and key ERAS lessons learned.  Dr. Nelson is the Deputy Head of the Department of Obstetrics & Gynecology at the Cumming School of Medicine in Calgary, Alberta, Canada and is Chief of Gynecologic Oncology at the Tom Baker Cancer Centre. He is also on the Executive Committee for the international ERAS® Society, and a lead author for the ERAS® Society gynecologic guidelines.2023-2024 ERAS Subcommittee Moderator and Podcast Script Editor:Lee-may Chen, MD2022-2023 Opioid/ERAS Subcommittee Members:Jing-Yi Chern, MD (Moderator)Amanika Kumar, MD (Podcast Script Editor)Podcast Invited Speaker:Gregg Nelson, MD, PhD 

Let’s face it, wellness is an ever-evolving concept. Listen in as we celebrate aspects of wellness throughout the SGO community. These are 10–20-minute quarterly snippets to highlight the authentic voices from SGO and beyond. Stay connected and foster community in between SGO meetings. You can find these episodes anywhere you get your SGO on the Go podcasts.To view the SGO Wellness Curriculum, click here. 

Join Dr. Kathryn Mills as she interviews Drs. Jubilee Brown, Ann Klopp, Joyce Liu, and Jyoti Mayadev to discuss the latest NRG Oncology updates on upcoming studies, research, and trials. The focus for the podcast is to bridge the gaps between SGO members and NRG Oncology.  Some questions covered during the interview:What are some of the upcoming trials in your disease site that you are most excited about?What advice would you give sites considering opening some of the trials that are available?How can sites get more efficient at screening and enrollment?How can sites increase enrollment of minorities?This episode was created by Dr. Kathryn Mills, a former 2022-2023 member of the SGO Education Committee's Clinical Trials Management/Concepts Subcommittee. Thanks to Drs. Jubilee Brown, Ann Klopp, Joyce Liu, and Jyoti Mayadev for your contribution to this episode. Moderator: Kathryn Mills, MDSpeakers:Jubilee Brown, MDAnn Klopp, MD, PhDJoyce Liu, MD, MPHJyoti Mayadev, MD 

This is the last of the three-part podcast series, Keeping up with the Chemos on Mirvetuximab soravtansine.  Our multidisciplinary panel will discuss the challenges with patient monitoring while on Mirvetuximab soravtansine. The panel discusses personal clinical experiences and lessons learned.  When to dose adjust and hold or even discontinue Mirvetuximab soravtansine. Once again, the session ends with take home points for patient monitoring while on Mirvetuximab soravtansine.  2022-2023 SGO Chemotherapy and Targeted Therapies Subcommittee Members and Moderators:Tracilyn Hall, MDJudith A. Smith, B.S., Pharm.D, BCOP, CPHQSpeakers:Julia Canestraro, OD, FAAO Karen Lyle, PA-CKathleen Moore, MD 

This is the second of the three-part podcast series, Keeping up with the Chemos on Mirvetuximab soravtansine. Our multidisciplinary panel will discuss the important information about creating chemotherapy orders, the drug preparation and administration of Mirvetuximab soravtansine. Focusing on eye drop prescriptions, home medications, and patient education. The session ends with general take home points on administration and toxicity prevention interventions. 2022-2023 SGO Chemotherapy and Targeted Therapies Subcommittee Members and Moderators:Tracilyn Hall, MDJudith A. Smith, B.S., Pharm.D, BCOP, CPHQSpeakers:Julia Canestraro, OD, FAAO Karen Lyle, PA-CKathleen Moore, MD

This is the first of the three-part podcast series, Keeping up with the Chemos on Mirvetuximab soravtansine. After going over some general information on Mirvetuximab soravtansine including mechanism of action and indication. The multidisciplinary panel will discuss the aspects of getting a team of APP, Optometrist, and Gynecologic Oncologist educated and prepared for giving Mirvetuximab soravtansine. The session wraps up with some key take home points on Mirvetuximab soravtansine.  2022-2023 SGO Chemotherapy and Targeted Therapies Subcommittee Members and Moderators:Tracilyn Hall, MDJudith A. Smith, B.S., Pharm.D, BCOP, CPHQSpeakers:Julia Canestraro, OD, FAAO Karen Lyle, PA-CKathleen Moore, MD

The goal of this podcast is to follow-up Key Concepts of enhanced recovery after surgery (ERAS), and this podcast is divided into sections referring to pre-operative, intraoperative, and postoperative considerations. We hope to provide some practical tips on how to develop a successful ERAS program at your institution. We acknowledge that all health systems are a little different. Yet there are some common strategies that can be used in developing collaborations.  In conclusion, how to implement ERAS is to foster communication between various team members, including the patient. We hope this podcast helps to set expectations and promote working in concert to bear the fruit of improved patient outcomes. 2022-2023 SGO Opioid/ERAS Subcommittee Members and Speakers:Lee-may Chen, MD; Subcommittee LeadJing-Yi Chern, MDSharmilee Korets, MDAmanika Kumar, MDAndras Ladanyi, MD, PhDMatthew Wagar, MDErin Hickey Zacholski, PharmD

Join Scott Richard, MD, co-chair of the SGO Taskforce for Board Certification Support, Yasmin Lyons, DO and Lisa Rauh, MD discuss the best cervical, vulvar and vaginal cancer resources when preparing for the ABOG oral board exam. This podcast episode addresses important resources and questions regarding study preparation, reviewing case list and joining a study group, visiting the SGO ConnectEd, meeting with your local radiation oncologist to discuss radiation in general and your individual patients managed, knowing landmark trials for prognostic factors (GOG 36), surgery for early-stage vulvar cancer, and more. The taskforce will offer six informative podcasts focused on high yield topics and best preparation practices. ABOG and SGO CollaborationDuring the SGO 2024 Annual Meeting on Women’s Cancer in San Diego, CA, representatives from The American Board of Obstetrics & Gynecology (ABOG) will join the SGO Taskforce for Board Certification Support to discuss logistics of the certifying exam as well as the assessment and scoring process and there will be a presentation covering radiation oncology. Keep an eye for this session opportunity when registering for the upcoming SGO 2024 Annual Meeting and be sure to sign up if interested in participating. We will also have three roundtable discussions where participants will meet in small groups with a taskforce facilitator to discuss hypothetical cases.        ResourcesClick here to access SGO ConnectEd to review additional resources on Cervical, Vulvar and Vaginal Cancer.NCCN guidelines, UpToDate, and GYOEDU.ORG.

Listen to Tracilyn Hall, MD, co-chair of the SGO Taskforce for Board Certification Support, interview Claire Hoppenot, MD and Alexander Melamed, MD discussing the best resources for Uterine Malignancies (endometrial cancer) and GTD Considerations when preparing for the ABOG oral board exam. This podcast episode addresses important resources and questions regarding reviewing for the ABOG Gynecology Oncology Certifying Exam.  They will help you reference the ABOG bulletin, resources on the SGO ConnectEd website, as well as relevant studies. In addition to this podcast, the taskforce will offer other informative podcasts focused on high yield topics and best preparation practices. ABOG and SGO CollaborationDuring the SGO 2024 Annual Meeting on Women’s Cancer in San Diego, CA,  representatives from The American Board of Obstetrics & Gynecology (ABOG) will join the SGO Taskforce for Board Certification Support to discuss logistics of the certifying exam as well as the assessment and scoring process and there will be a presentation covering radiation oncology. Keep an eye for this session opportunity when registering for the upcoming SGO 2024 Annual Meeting and be sure to sign up if interested in participating. We will also have three roundtable discussions where participants will meet in small groups with a taskforce facilitator to discuss hypothetical cases. ResourcesClick here to access SGO ConnectEd to review additional resources on Uterine Malignancies and GTD Considerations.The ABOG Gynecology Oncology Exam bulletin, which has a comprehensive list of possible topics. As for some just general good places to focus as it gets closer to the time of the exam think about NCCN guidelines, UpToDate, and GYOEDU.ORG.

Join Scott Richard, MD, co-chair of the SGO Taskforce for Board Certification Support, Anna Beavis, MD and Robert Neff, MD discuss the best ovarian cancer resources on surgical considerations, chemotherapy, and genetic testing when preparing for the ABOG oral board exam. This podcast episode addresses important resources and questions regarding study preparation, reviewing case list and grouping your cases to see their similarities/differences, management of toxicities of common targeted therapies for gynecologic cancers, the benefits of joining a study group, attending the SGO Annual Meeting sessions to gain insight, knowing the FDA indications, and more. The taskforce will offer six informative podcasts focused on high yield topics and best preparation practices.  ABOG and SGO CollaborationDuring the SGO 2024 Annual Meeting on Women’s Cancer in San Diego, CA,  representatives from The American Board of Obstetrics & Gynecology (ABOG) will join the SGO Taskforce for Board Certification Support to discuss logistics of the certifying exam as well as the assessment and scoring process and there will be a presentation covering radiation oncology. Keep an eye for this session opportunity when registering for the upcoming SGO 2024 Annual Meeting and be sure to sign up if interested in participating. We will also have three roundtable discussions where participants will meet in small groups with a taskforce facilitator to discuss hypothetical cases. ResourcesClick here to access SGO ConnectEd to review additional resources on Ovarian Cancer.Review NCCN guidelines, UpToDate, and GYOEDU.ORG.Listen to Key Concepts of Enhanced Recovery After Surgery. ERAS–Why Do We Do It? There are SGO ConnectEd chemo flash cards that are high yield when it comes to toxicities. Special thanks to Drs. Beavis and Neff for your contribution to this episode.

This is the last of the three-part podcast series, Keeping up with the Chemos on Lenvatinib/pembrolizumab.  Our multidisciplinary panel will discuss the challenges with patient monitoring while on Lenvatinib/pembrolizumab.  The panel discusses personal clinical experiences and lessons learned.  When to dose adjust and hold or even discontinue Lenvatinib/pembrolizumab. Once again, the session ends with take home points for patient monitoring while on Lenvatinib/pembrolizumab.  2022-2023 SGO Chemotherapy/Targeted Therapies Subcommittee Members and Moderators:Tracilyn Hall, MDJudith A. Smith, B.S., Pharm.D, BCOP, CPHQSpeakers:Jennifer MacDonald, Pharm.D, BCOPPamela Soliman, MD

This is the second of the three-part podcast series, Keeping up with the Chemos on Lenvatinib/pembrolizumab. Our multidisciplinary panel will discuss the important information about creating chemotherapy orders, the drug preparation and administration of Lenvatinib/pembrolizumab. Focusing on specialty pharmacy and patient education when taking Lenvatinib at home. The session ends with general take home points on administration and toxicity prevention interventions. 2022-2023 SGO Chemotherapy/Targeted Therapies Subcommittee Members and Moderators:Tracilyn Hall, MDJudith A. Smith, B.S., Pharm.D, BCOP, CPHQSpeakers:Dew Hilton, Specialty Pharmacy Technician Jennifer MacDonald, Pharm.D, BCOPPamela Soliman, MD